insights_auto
Why is RCEL up 4.17%?
Dive Deeperchevron_right
RCEL:NASDAQ
AVITA Medical Inc
$13.25
arrow_upward
+4.17%(+0.53) 1D
$13.31
arrow_upward
+0.45% (+0.060)bedtimeAfter hours
Closed: Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCEL...
Open
$12.64
High
$13.48
Low
$12.53
Mkt. cap
409.78M
Avg. vol.
300.92K
Volume
420.76K
52-wk high
$13.48
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
Open
$12.64
High
$13.48
Low
$12.53
Mkt. cap
409.78M
Avg. vol.
300.92K
Volume
420.76K
52-wk high
$13.48
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
Kalkine Media
·
5 hours ago
AVITA Medical Director Dr. Michael Tarnoff Converts 8,750 RSUs into Common Shares
Kalkine
·
5 hours ago
AVITA Medical Director Dr. Michael Tarnoff Receives RSU Vesting Into Common Stock
AD HOC NEWS
·
16 hours ago
Avita Medical stock gained 5.91 percent near its yearly high
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com